Phosphate control in reducing FGF23 levels in hemodialysis patients - Wikidata - awgldk - TriplyDB

Phosphate control in reducing FGF23 levels in hemodialysis patients

Phosphate control in reducing FGF23 levels in hemodialysis patients

http://www.wikidata.org/entity/Q58797979

about

Phosphate control in reducing FGF23 levels in hemodialysis patients

http://www.wikidata.org/entity/Q58797979

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Phosphate control in reducing FGF23 levels in hemodialysis patients

@en

Phosphate control in reducing FGF23 levels in hemodialysis patients

@nl

type

label

Phosphate control in reducing FGF23 levels in hemodialysis patients

@en

Phosphate control in reducing FGF23 levels in hemodialysis patients

@nl

prefLabel

Phosphate control in reducing FGF23 levels in hemodialysis patients

@en

Phosphate control in reducing FGF23 levels in hemodialysis patients

@nl

P1433

Q58797979-1AC14C86-7FA1-4AC8-A30A-670B66263A07

P1476

Q58797979-5FD43963-71C6-4488-BB4C-AFEF0329BE4C

P2093

Q58797979-0D1F7912-78C3-442B-97C4-8C7128A09426

Q58797979-12290B46-ACCA-40BF-B1A0-564F71995E43

Q58797979-12C86743-3C00-48E5-AC5D-33F98FD2345C

Q58797979-1D2B657E-656B-4275-9667-C83ACDF4B66A

Q58797979-208C5DEC-E8B8-44A4-AA87-8AD823A0473B

Q58797979-28E351AC-1DD1-4AA1-95AC-1F05D9751856

Q58797979-5183E730-35EF-4013-BD61-8F820563F70F

Q58797979-5B3FBF25-7AA7-4FFD-93A4-AA55A0CEE434

Q58797979-696296B8-7D14-48DF-8E32-B18CE1CB7736

Q58797979-885877BB-9680-4DFE-915E-3F1EB2008A12

P2860

Q58797979-04686F61-F3AF-42D2-A6C0-EB197FA35901

Q58797979-09701F4A-5EE5-4907-83BB-84FAF396B84E

Q58797979-0C8D4FF4-ECB9-467B-B1A6-0087EAAEA91B

Q58797979-0E5E7130-4512-400B-B545-7A0DAE3077B5

Q58797979-116A84F3-812C-46DD-B708-3AB6403DB8B4

Q58797979-12624DA3-E42F-4809-823D-975FBDAB65A9

Q58797979-13D5D28D-F9E0-47A2-9171-DA3F00B74BCE

Q58797979-197592F5-CEAC-4CE5-A7A6-C41237DE70C5

Q58797979-1BD6634C-C4CC-4623-8A57-66D717C05054

Q58797979-23261557-496D-463F-9F6E-8C53DD6EF5E5

P304

Q58797979-DC0CC1D2-8937-42F6-A158-1819DA84398E

P31

Q58797979-72BD8666-13CC-415E-B6C4-789A4CAA6EBA

P356

Q58797979-FCCDD143-1E1A-4C1F-A400-65F067592642

P407

Q58797979-4EC07BFE-9932-43F8-A621-18331608E6E0

P433

Q58797979-578610CB-9AAC-4EB5-8055-CFC9F783AF8F

P478

Q58797979-FE2281A0-AD7F-403C-BEBA-505FC46B1F79

P50

Q58797979-23536125-2058-4600-9A30-1468CE088045

Q58797979-6C35604C-4E32-4182-9EF2-E5D5EF3E4915

P577

Q58797979-20D18021-D8C9-4E6D-8710-F5D8E4C5817A

P698

Q58797979-76C3329E-A651-470A-8C4E-E4F3D8F5F770

P932

Q58797979-CF3B6E2E-8032-439D-A745-36721A270A48

P356

JOURNAL.PONE.0201537

P1433

P1476

Phosphate control in reducing FGF23 levels in hemodialysis patients

@en

P2093

Alejandro Martin-Malo

http://www.w3.org/2001/XMLSchema#string

Arnold Felsenfeld

http://www.w3.org/2001/XMLSchema#string

Francisco Caravaca

http://www.w3.org/2001/XMLSchema#string

Juan R Muñoz-Castañeda

http://www.w3.org/2001/XMLSchema#string

M Antonia Alvarez-Lara

http://www.w3.org/2001/XMLSchema#string

M Luisa Agüera

http://www.w3.org/2001/XMLSchema#string

M Victoria Pendon-Ruiz de Mier

http://www.w3.org/2001/XMLSchema#string

Maria E Rodríguez-Ortiz

http://www.w3.org/2001/XMLSchema#string

Pedro Aljama

http://www.w3.org/2001/XMLSchema#string

Sagrario Soriano

http://www.w3.org/2001/XMLSchema#string

P2860

FGF23 and mineral metabolism, implications in CKD-MBD

PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop

FGF23 fails to inhibit uremic parathyroid glands

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study

High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD.

P304

e0201537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0201537

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Mariano Rodríguez

P577

2018-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30086150

http://www.w3.org/2001/XMLSchema#string

P932

6080760

http://www.w3.org/2001/XMLSchema#string